K. Brattegaard et al., RAPID AND SIMPLE SCREENING AND SUPPLEMENTAL TESTING FOR HIV-1 AND HIV-2 INFECTIONS IN WEST-AFRICA, AIDS, 7(6), 1993, pp. 883-885
Objective: To evaluate a combination of rapid tests as a strategy for
screening and supplemental testing of serum for HIV-1 and/or HIV-2 ant
ibodies. Design: Cross-sectional evaluation. Setting: Projet RETRO-Cl,
an AIDS research project in Abidjan, Cote d'Ivoire. Methods: Serum sp
ecimens were collected from 1000 consecutive women giving birth in an
Abidjan maternal and child health centre and from 185 hospitalized pat
ients. All serum specimens were tested for HIV-1 and HIV-2 antibodies
by whole-virus enzyme immunoassay; repeatedly reactive specimens were
further tested by virus-specific Western blot and synthetic peptide-ba
sed tests. This was the reference strategy against which the algorithm
under evaluation was compared. All specimens were subsequently tested
by a mixed (HIV-1 and HIV-2) recombinant antigen-based test (Abbott T
estpack), followed, if positive, by a rapid synthetic peptide-based te
st (Genetic Systems Genie) as a supplemental test. Results: According
to the reference strategy the prevalence of HIV-1 and/or HIV-2 infecti
on was 13% among the pregnant women and 78% among the hospitalized pat
ients. Compared with the reference strategy, the combination of rapid
tests was associated with a sensitivity of 99.6%, a specificity of 99.
9%, and positive and negative predictive values of 99.6 and 99.9%, res
pectively. Four per cent of HIV-2-positive and 1% of HIV-1-positive sp
ecimens were considered dually reactive by the rapid test combination.
Conclusions: Synthetic peptide-based tests provide an alternative to
Western blots for supplemental testing for HIV-1 and HIV-2. This combi
nation of rapid tests offers performance characteristics comparable to
an enzyme immunoassay and Western blot-based strategy, without requir
ing running water, electricity, or a well-developed laboratory. High-q
uality serodiagnosis of HIV-1 and HIV-2 infections is possible at the
most peripheral levels of the health-care system in developing countri
es, the limiting factors being the costs of tests and training of staf
f.